drugset / Trial / NCT04625855
Study of the Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the absorption, metabolism, and excretion of \[14C\]-TBPM-PI-HBr and to characterize and determine the metabolites present in plasma, urine, and where possible, feces in healthy male subjects following a single oral administration.
Timeline
- Start
- 2020-09-30
- Primary completion
- 2020-10-16
- Completion
- 2020-10-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TBPM-PI-HBr | Small molecule | 600 mg | Oral |
Indications
No indication recorded.